Review
Copyright ©The Author(s) 2016.
World J Gastrointest Oncol. Oct 15, 2016; 8(10): 735-744
Published online Oct 15, 2016. doi: 10.4251/wjgo.v8.i10.735
Table 1 Nanomedicine-based therapies against cancer stem cells of the digestive system
Tumor typesNanomedicineRef.
Drug delivery
Gastric cancerSAL-loaded carbon nanotubes functionalized with HA[82]
Liver cancerSAL-loaded iRGD-conjugated DSPE-PEG2000 nanomicelles[83]
Colorectal cancerCurcumin-loaded CSO-SA micelles[87]
Oxaliplatin-loaded CSO-SA micelles[88]
Gene delivery
Liver canceranti-EpCAM-monoclonal-antibody-labeled block copolymer vesicle[89]
Colorectal cancerWtp53 gene loaded scL nanocomplex[90]
Colon cancerMDR1 siRNA loaded lipid nanoparticles[91]
Gastric cancermiR-200c loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles[94]
Targeted delivery
Gastric cancerSAL-loaded carbon nanotubes functionalized with HA[82]
Liver canceranti-CD44 antibody-mediated liposomal nanoparticle loaded of doxorubicin[96]
CD90-targeted thermosensitive magnetoliposomes-encapsulated 17-AAG[97]
Combinational delivery
Gastric cancerNanoparticle co-loaded miR-200c and DOC[99]
Liver cancermicellar nanoparticle co-delivering platinum (IV) prodrug and siNotch1[100]
Colorectal cancerLiposomes co-encapsulated irinotecan and floxuridine[101]
Colon cancerNanoliposomes co-encapsulated vincristine and topotecan[102]